Strategic partnership Syneos Health has recently formed a strategic partnership with KAI Conversations to bring AI-driven field insights to the US biopharma market. This indicates openness to integrating AI-powered tools and external analytics, presenting an upsell opportunity for enhanced analytics, coaching, and personalized learning modules within MODAL.

AI and personalization MODAL ecosystem emphasizes AI-powered recommendations, real-time learner insights, and precision coaching. This strong focus on personalized learning experiences aligns with pharma clients seeking targeted training for field teams, regulatory updates, and therapeutic area specialization—a solid angle for expanding to more clients or deeper deployments.

Digital patient access Industry discussions highlight digital innovation transforming patient access programs. There is potential to offer integrated training for patient support workflows, hub services, and digital engagement strategies to biopharma companies looking to scale access programs alongside their digital transformation initiatives.

Expansion activity Syneos Health has shown regional and market expansion activity, including acquisitions and partnerships, signaling growth and demand for scalable training solutions in new markets such as Asia and ongoing digital health modernization—opportunities to position MODAL as the standard training backbone for multinational rollouts.

Evidence-driven impact The emphasis on measurable impact and behavior change suggests a value proposition centered on outcomes analytics, training effectiveness, and KPIs like performance improvement and behavior change. This can be leveraged to pursue multi-year licensing, executive sponsorship programs, and expanded analytics engagements with pharma clients.